Shots: Theramax acquires commercialization rights of Zoely, allowing it to commercialize the therapy in 50+ countries globally. Earlier, Theramax has right to commercialize Zoely in eleven countries in the EU […]readmore
Tags : Acquire
Shots: MD Anderson signs an asset purchase agreement with Bellicum to acquire its 60,000-square-foot facility in Houston including its technical operation, quality staff, manufacturing, office and laboratory space for $15M. […]readmore
Shots: BioNtech to acquire Neon in an all-stock transaction for $67M or $2.18/ share of Neon based on the closing price of BioNTechs’ ADS of $34.55 & at a premium […]readmore
Shots: Wuxi Biologic to take over operations of Bayer’s manufacturing plants in Leverkusen, Germany and purchase its associated equipment in combination with a long-term lease contract for the building As […]readmore
Shots: Pfizer’s to receive $75M up front, $365M development & commercial milestones and royalties on sales of the product. Biogen plans to develop Pfizer’s PF-05251749 for Sundowning in AD and […]readmore
Shots: Lilly acquires Dermira in all-cash transaction making total deal value ~$1.1B at $18.75/share representing premium of 86% to the 60-day volume-weighted average trading price of Dermira’s stock ending on […]readmore
Shots: J&J acquires TARIS Biomedical while TARIS to continue research in Lexington, Massachusetts and will also become part of Janssen R&D’s Oncology Therapeutic Area. Additionally, the companies will focus on […]readmore
Shots: Charles River to acquire HemaCare in all cash transactions at $25.40 /share, making a total deal value $380M with a premium of 33% to HemaCare’s volume-weighted average stock price […]readmore
Shots: Assertio to receive $127.5M including $75M up front in cash and $52.5M as royalties when Gralise net sales reach $75M while Alvogen will get all responsibilities related to the […]readmore
Shots: Merck to acquire Arqule in all-cash transactions at $20/share, making a total deal value $2.7B. The transaction is expected to be completed in Q1’20 The focus of the acquisition […]readmore